The impact of smoking on radical cystectomy complications increases in elderly patients
Background Smoking, the most common risk factor for bladder cancer (BC), is associated
with increased complications after radical cystectomy (RC), poorer oncologic outcomes, and …
with increased complications after radical cystectomy (RC), poorer oncologic outcomes, and …
Trends in management and outcomes among patients with urothelial carcinoma undergoing radical cystectomy from 1995 to 2015: the Memorial Sloan Kettering …
N Almassi, EK Cha, EA Vertosick, C Huang… - The Journal of …, 2020 - auajournals.org
Purpose: We evaluated trends in oncologic characteristics and outcomes as well as
perioperative management among patients undergoing radical cystectomy at Memorial …
perioperative management among patients undergoing radical cystectomy at Memorial …
[HTML][HTML] Health-related quality of life with adjuvant nivolumab after radical resection for high-risk muscle-invasive urothelial carcinoma: results from the phase 3 …
JA Witjes, MD Galsky, JE Gschwend… - European urology …, 2022 - Elsevier
Background The programmed death-1 (PD-1) inhibitor nivolumab prolongs disease-free
survival in patients with muscle-invasive urothelial carcinoma (MIUC). Objective To evaluate …
survival in patients with muscle-invasive urothelial carcinoma (MIUC). Objective To evaluate …
Circular RNAs and cancer: Opportunities and challenges
Circular RNAs (circRNAs) are covalently circularized RNA moieties that despite being
relatively abundant were only recently identified and have only begun to be investigated …
relatively abundant were only recently identified and have only begun to be investigated …
α-E-catenin (CTNNA1) inhibits cell proliferation, invasion and EMT of bladder cancer
Q Chi, H Xu, D Song, Z Wang, Z Wang… - Cancer management …, 2020 - Taylor & Francis
Aim Bladder cancer (BLCA) is an urogenital system tumor with a high morbidity. We aimed
to explore the function and potential mechanism of α-E-catenin (CTNNA1) in BLCA. Methods …
to explore the function and potential mechanism of α-E-catenin (CTNNA1) in BLCA. Methods …
Comprehensive analysis of CPA4 as a poor prognostic biomarker correlated with immune cells infiltration in bladder cancer
C Wei, Y Zhou, Q Xiong, M Xiong, Y Hou, X Yang… - Biology, 2021 - mdpi.com
Simple Summary The overexpression of Carboxypeptidase A4 (CPA4) has been observed
in plenty of types of cancer and has been elucidated to promote tumor growth and invasion; …
in plenty of types of cancer and has been elucidated to promote tumor growth and invasion; …
Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder …
J Fu, W Zhang, T Jiang - Frontiers in Genetics, 2022 - frontiersin.org
Background: Immunogenic cell death (ICD) plays an important role in several malignancies.
However, the role of ICD-mediated patterns in bladder cancer (BCA) remains unknown …
However, the role of ICD-mediated patterns in bladder cancer (BCA) remains unknown …
Bladder cancer stage development, 2004-2014 in Europe compared with the united states: Analysis of European population-based cancer registries, the united states …
GB Schulz, T Grimm, A Buchner, F Jokisch… - Clinical Genitourinary …, 2020 - Elsevier
Background The purpose of this study was to analyze trends of bladder cancer (BC) stages
and incidence in Europe and the United States (US). Materials and Methods Tumor stages …
and incidence in Europe and the United States (US). Materials and Methods Tumor stages …
Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study …
Y Hu, Q Zhao, J Rao, H Deng, H Yuan, B Xu - BMC public health, 2014 - Springer
Background Prostate cancer is the fifth most common cancer affecting men of all ages in
China, but robust surveillance data on its occurrence and outcome is lacking. The specific …
China, but robust surveillance data on its occurrence and outcome is lacking. The specific …
Management of bladder cancer patients with clinical evidence of lymph node invasion (cN+)
B Małkiewicz, A Gurwin, J Karwacki, K Nagi… - Cancers, 2022 - mdpi.com
Simple Summary This review presents the current status of diagnostic and treatment options
in bladder cancer (BCa) patients with clinically positive lymph nodes (cN+). There is no …
in bladder cancer (BCa) patients with clinically positive lymph nodes (cN+). There is no …